二叶式主动脉瓣病无需更早外科干预
该研究回顾2428例升主动脉瘤患者(554例二叶式主动脉瓣,1874例三叶式主动脉瓣),分析主动脉增长速率与不良主动脉事件。二叶式主动脉瓣患者增长速率为0.20 cm/年,三叶式主动脉瓣为0.17 cm/年(P=.009),但二叶式主动脉瓣患者不良事件风险更低。作者认为二叶式主动脉瓣升主动脉瘤的手术阈值不应不同于三叶式主动脉瓣,三叶式主动脉瓣(及二叶式主动脉瓣)患者可考虑在5.0 cm时于专家中心行预防性手术。
要点
- 二叶式主动脉瓣患者主动脉增长速率为0.20 cm/年,三叶式主动脉瓣为0.17 cm/年(P=.009)。
- 二叶式主动脉瓣患者不良主动脉事件年发生率低于三叶式主动脉瓣患者。
- 作者认为二叶式主动脉瓣升主动脉瘤手术阈值不应不同于三叶式主动脉瓣,可考虑5.0 cm于专家中心预防性手术。
核心结论
- 二叶式主动脉瓣升主动脉瘤的手术修复阈值不应不同于三叶式主动脉瓣。
- 作者建议三叶式主动脉瓣(及二叶式主动脉瓣)患者在专家中心可考虑5.0 cm时行预防性手术。
研究设计与样本
- 回顾性分析2428例升主动脉瘤患者(554例二叶式主动脉瓣,1874例三叶式主动脉瓣)术前主动脉直径与长期并发症。
- 计算增长速率、年并发症率、无事件生存率及并发症风险与主动脉大小的关系。
- 通过综合六途径方法实现长期随访和精确死因粒度。
主要发现
- 二叶式主动脉瓣与三叶式主动脉瓣患者主动脉增长速率分别为0.20 cm/年和0.17 cm/年(P=.009),且速率随主动脉大小增加而增加。
- 年不良主动脉事件率随升主动脉瘤大小增加而升高,二叶式主动脉瓣患者较低。
- 不良主动脉事件的相对风险随主动脉直径呈指数增加。
- 二叶式主动脉瓣患者全因及升主动脉特异性不良主动脉事件风险较低。
- 年龄校正10年无事件生存率二叶式主动脉瓣患者显著更优,二叶式主动脉瓣为A型夹层、破裂和升主动脉死亡的 protective factor。
关键数值与推荐
- 二叶式主动脉瓣与三叶式主动脉瓣患者主动脉增长速率分别为0.20 cm/年和0.17 cm/年(P=.009)。
- 作者建议三叶式主动脉瓣(及二叶式主动脉瓣)患者在专家中心可考虑5.0 cm时行预防性手术。
临床怎么用
- 作者认为二叶式主动脉瓣升主动脉瘤的手术修复阈值不应不同于三叶式主动脉瓣。
- 作者建议三叶式主动脉瓣(及二叶式主动脉瓣)患者在专家中心可考虑5.0 cm时行预防性手术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Guidelines for surgical correction of patients with ascending thoracic aortic aneurysm (ATAA) with a bicuspid aortic valve (BAV) have oscillated over the years. In this study, we outline the natural history of the ascending aorta in patients with BAV and trileaflet aortic valve (TAV) ATAA followed over time, to ascertain if their behavior differs and to determine if a different threshold for intervention is required. METHODS: Aortic diameters and long-term complications (ie, adverse aortic events) of 2428 patients (554 BAV and 1874 TAV) with ATAA before operative repair were reviewed. Growth rates, yearly complication rates, event-free survival, and risk of complications as a function of aortic size were calculated. Long-term follow-up and precise cause of death granularity was achieved via a comprehensive 6-pronged approach. RESULTS: Aortic growth rate in patients with BAV vs TAV ATAA was 0.20 and 0.17 cm/year, respectively (P = .009), with the rate increasing with increasing aortic size. Yearly adverse aortic events rates increased with ATAA size and were lower for patients with BAV. The relative risk of adverse aortic events exhibited an exponential increase with aortic diameter. Patients with BAV had a lower all-cause and ascending aorta-specific adverse aortic events hazard. Age-adjusted 10-year event-free survival was significantly better for patients with BAV, and BAV emerged as a protective factor against type A dissection, rupture, and ascending aortic death. CONCLUSIONS: The threshold for surgical repair of ascending aneurysm with BAV should not differ from that of TAV. Prophylactic surgery should be considered at 5.0 cm for patients with TAV (and BAV) at expert centers.
引用
- Zafar MA, Wu J, Vinholo TF, et al. Bicuspid aortopathy does not require earlier surgical intervention. J Thorac Cardiovasc Surg. 2023. PMID: 37088130. doi:10.1016/j.jtcvs.2023.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。